Blinded Envudeucitinib

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque PsoriasisNCT06846541ALMSPhase 3Active not recruiting2028-11Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.